Pulling SEC filings + quote and writing the call…

Advanced Flower Capital Inc.
Next earnings Aug 12, 2026 · consensus $0.13 EPS, $7.00M rev
Last earnings +11.6% on 2026-05-07
Cannabis lender trading at ~0.4x book, but a collapsing loan book and first annual loss make it a deep-value trap, not a bargain.
Revenue $24.6M · FY2025
AFC is a specialty cannabis lender that just elected BDC status effective Jan 1, 2026 — a fresh regulatory regime the 10-K itself flags via 'limited operating history as a BDC.' The numbers describe a business in retreat: revenue has fallen four straight years (74.7M → 63.9M → 45.7M → 24.6M), with FY2025 down 46.2% YoY, and the July-2024 SUNS spin-off stripped out the CRE portfolio, shrinking the remaining engine. FY2025 flipped to a -20.7M net loss (net margin -84.2%, ROE -11.8%) after two years of solid profit, and cash was cut 62.7% to 38.6M while accumulated deficit deepened to -83.4M. This is not a soft patch — it is credit deterioration showing up in the P&L.
The MD&A makes the cause concrete: Private Company K was placed in consensual receivership in Jan 2025, AFC initiated mortgage foreclosure against Subsidiary of Private Company G over a cultivation facility (citing a lost cannabis license and payment defaults), and by April 2025 was suing guarantors. The Risk Factors underscore that the portfolio is 'concentrated in a limited number of loans,' so a single distressed borrower moves the whole book — exactly what the loss reflects. Cannabis-specific risk (federal enforcement, borrower license loss, illiquid collateral) compounds the concentration.
Is AFCG a buy? The one-page verdict, explained →
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | $74.7M | $63.9M | $45.7M | $24.6M |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | — | — | $21.0M | $16.8M | -$20.7M |
| Diluted EPS | $1.52 | $1.79 | $1.02 | $0.78 | -$0.95 |
| Net margin | — | — | 32.8% | 36.8% | -84.2% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Entered new material loan/credit agreement, adding a direct debt obligation
Reg FD disclosure (Item 7.01) — investor update/presentation
Disclosed shareholder meeting voting results
Q1'26: revenue decline continues as BDC conversion takes hold
Q1'26: revenue decline continues as BDC conversion takes hold
Annual meeting proxy — routine board/governance items
Entered material agreement creating a new financing obligation
FY25: revenue -46%, -$20.7M loss, elected BDC status Jan 2026
FY25: revenue -46%, -$20.7M loss, elected BDC status Jan 2026
Sources: SEC EDGAR (CIK 0001822523, latest 10-Q filed 2026-05-07) · EODHD · Proprietary analysis · as of 7/3/2026, 4:40:49 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 3, 2026, 12:40 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 1 open-market buy · 0 sales
| 2026-05-14 | TANNENBAUM LEONARD M Director | Buy | 90.6K @ $2.84 | $257K |
| 2026-03-31 | Tannenbaum Robyn President and CIO | Buy | 7.00K @ $2.80 | $19.6K |
| 2026-03-31 | TANNENBAUM LEONARD M Director | Buy | 29.0K @ $2.76 | $80.2K |
| 2026-03-27 | TANNENBAUM LEONARD M Director | Buy | 4.30K @ $2.60 | $11.2K |
| 2026-03-26 | TANNENBAUM LEONARD M Director | Buy | 19.7K @ $2.60 | $51.3K |
| 2026-03-24 | TANNENBAUM LEONARD M Director | Buy | 44.9K @ $2.59 | $116K |
| 2026-03-23 | TANNENBAUM LEONARD M Director | Buy | 14.4K @ $2.59 | $37.2K |
| 2026-03-20 | TANNENBAUM LEONARD M Director | Buy | 115K @ $2.55 | $294K |
| 2026-03-19 | TANNENBAUM LEONARD M Director | Buy | 60.6K @ $2.59 | $157K |
| 2026-03-18 | TANNENBAUM LEONARD M Director | Buy | 90.6K @ $2.59 | $235K |
| 2026-03-16 | TANNENBAUM LEONARD M Director | Buy | 34.3K @ $2.59 | $88.8K |
| 2026-03-13 | TANNENBAUM LEONARD M Director | Buy | 15.0K @ $2.60 | $39.0K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median